Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-31

Clinical Trial Update: Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression [NA]

View source ↗

Summary

This clinical trial update analyzes integrase resistance in HIV-infected patients who interrupted raltegravir due to incomplete viral suppression, aiming to cha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isentress (Raltegravir)

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: HIV Infection | NA | Status: UNKNOWN